On Jan. 31, aducanumab, a pricey drug approved for treatment of early-stage Alzheimer's disease, was withdrawn from the market. And in early March, the Food and Drug Administration delayed its decision regarding whether to ...
Mar 14, 2024
0
0
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers potential clues to why some ...
Mar 7, 2024
0
597
Purdue University researchers have developed a patented therapeutic strategy for Lowe syndrome, an incurable and rare genetic disorder, by repurposing two drugs previously approved by the U.S. Food and Drug Administration ...
Feb 29, 2024
0
0
A new drug could offer a powerful way to sensitize tumors to immunotherapy, a new trial suggests. The results have been published in the Journal of Clinical Investigation.
Feb 27, 2024
0
1
Over the past decade or so, scientists have amassed an impressive arsenal of weapons to address the multifaceted, complex challenge of mental illness, from new genomic analysis tools and high-resolution neuroimaging technologies, ...
Feb 26, 2024
0
45
Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines. They're easy to produce precisely. They're safe and potentially more effective. And they ...
Feb 23, 2024
0
39
A team of Rutgers undergraduates has shown that an experimental drug known as Yoda1 may help drain cranial waste plus neurotoxins that cause Alzheimer's disease and other forms of dementia.
Feb 19, 2024
0
92
It was a last-ditch effort. For years doctors had tried to keep a patient's recurrent drug-resistant bacterial blood infection at bay, but it kept coming back and antibiotics were no longer working.
Feb 14, 2024
0
13
A team of medical researchers with affiliations to British multinational pharmaceutical and biotechnology company GlaxoSmithKline (GSK) has found that a new antibiotic drug the company developed to treat urinary tract infections ...
Patient-reported outcomes are important indicators of how cancer drugs impact patients' lives. By assessing the benefits and risks of drugs from a patient's perspective, scientists and physicians can improve the development ...
Feb 6, 2024
0
0
